Global Small Molecule Targeted Anti-cancer Drug Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 EGFR
  • 1.2.3 ALK
  • 1.2.4 Bcr-Abl
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Small Molecule Targeted Anti-cancer Drug Market Share by Application: 2020 VS 2026
  • 1.3.2 Liver Cancer
  • 1.3.3 Colorectal Cancer
  • 1.3.4 Lung Cancer
  • 1.3.5 Gastric Cancer
  • 1.3.6 Breast Cancer
  • 1.3.7 Esophageal Cancer
  • 1.3.8 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Small Molecule Targeted Anti-cancer Drug Market Perspective (2015-2026)
• 2.2 Global Small Molecule Targeted Anti-cancer Drug Growth Trends by Regions
  • 2.2.1 Small Molecule Targeted Anti-cancer Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Small Molecule Targeted Anti-cancer Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Small Molecule Targeted Anti-cancer Drug Players by Market Size
  • 3.1.1 Global Top Small Molecule Targeted Anti-cancer Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Players (2015-2020)
• 3.2 Global Small Molecule Targeted Anti-cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Small Molecule Targeted Anti-cancer Drug Revenue
• 3.4 Global Small Molecule Targeted Anti-cancer Drug Market Concentration Ratio
  • 3.4.1 Global Small Molecule Targeted Anti-cancer Drug Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Anti-cancer Drug Revenue in 2019
• 3.5 Key Players Small Molecule Targeted Anti-cancer Drug Area Served
• 3.6 Key Players Small Molecule Targeted Anti-cancer Drug Product Solution and Service
• 3.7 Date of Enter into Small Molecule Targeted Anti-cancer Drug Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Targeted Anti-cancer Drug Breakdown Data by Type (2015-2026)

• 4.1 Global Small Molecule Targeted Anti-cancer Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Type (2021-2026)

5 Small Molecule Targeted Anti-cancer Drug Breakdown Data by Application (2015-2026)

• 5.1 Global Small Molecule Targeted Anti-cancer Drug Historic Market Size by Application (2015-2020)
• 5.2 Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Small Molecule Targeted Anti-cancer Drug Market Size (2015-2026)
• 6.2 North America Small Molecule Targeted Anti-cancer Drug Market Size by Type (2015-2020)
• 6.3 North America Small Molecule Targeted Anti-cancer Drug Market Size by Application (2015-2020)
• 6.4 North America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Small Molecule Targeted Anti-cancer Drug Market Size (2015-2026)
• 7.2 Europe Small Molecule Targeted Anti-cancer Drug Market Size by Type (2015-2020)
• 7.3 Europe Small Molecule Targeted Anti-cancer Drug Market Size by Application (2015-2020)
• 7.4 Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Small Molecule Targeted Anti-cancer Drug Market Size (2015-2026)
• 8.2 China Small Molecule Targeted Anti-cancer Drug Market Size by Type (2015-2020)
• 8.3 China Small Molecule Targeted Anti-cancer Drug Market Size by Application (2015-2020)
• 8.4 China Small Molecule Targeted Anti-cancer Drug Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Small Molecule Targeted Anti-cancer Drug Market Size (2015-2026)
• 9.2 Japan Small Molecule Targeted Anti-cancer Drug Market Size by Type (2015-2020)
• 9.3 Japan Small Molecule Targeted Anti-cancer Drug Market Size by Application (2015-2020)
• 9.4 Japan Small Molecule Targeted Anti-cancer Drug Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size (2015-2026)
• 10.2 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size by Type (2015-2020)
• 10.3 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size by Application (2015-2020)
• 10.4 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 Astrazeneca
  • 11.1.1 Astrazeneca Company Details
  • 11.1.2 Astrazeneca Business Overview
  • 11.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.1.4 Astrazeneca Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020))
  • 11.1.5 Astrazeneca Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Novartis Business Overview
  • 11.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.2.4 Novartis Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.2.5 Novartis Recent Development
• 11.3 Millennium Pharmaceuticals
  • 11.3.1 Millennium Pharmaceuticals Company Details
  • 11.3.2 Millennium Pharmaceuticals Business Overview
  • 11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.3.5 Millennium Pharmaceuticals Recent Development
• 11.4 Bayer
  • 11.4.1 Bayer Company Details
  • 11.4.2 Bayer Business Overview
  • 11.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.4.4 Bayer Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.4.5 Bayer Recent Development
• 11.5 Exelixis
  • 11.5.1 Exelixis Company Details
  • 11.5.2 Exelixis Business Overview
  • 11.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.5.4 Exelixis Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.5.5 Exelixis Recent Development
• 11.6 Abbvie
  • 11.6.1 Abbvie Company Details
  • 11.6.2 Abbvie Business Overview
  • 11.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.6.4 Abbvie Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.6.5 Abbvie Recent Development
• 11.7 Boehringer-Ingelheim
  • 11.7.1 Boehringer-Ingelheim Company Details
  • 11.7.2 Boehringer-Ingelheim Business Overview
  • 11.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.7.5 Boehringer-Ingelheim Recent Development
• 11.8 Eisai
  • 11.8.1 Eisai Company Details
  • 11.8.2 Eisai Business Overview
  • 11.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.8.4 Eisai Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.8.5 Eisai Recent Development
• 11.9 Pfizer
  • 11.9.1 Pfizer Company Details
  • 11.9.2 Pfizer Business Overview
  • 11.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.9.4 Pfizer Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.9.5 Pfizer Recent Development
• 11.10 Bristol-Myers Squibb
  • 11.10.1 Bristol-Myers Squibb Company Details
  • 11.10.2 Bristol-Myers Squibb Business Overview
  • 11.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Introduction
  • 11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 11.10.5 Bristol-Myers Squibb Recent Development
• 11.11 Roche
  • 10.11.1 Roche Company Details
  • 10.11.2 Roche Business Overview
  • 10.11.3 Roche Small Molecule Targeted Anti-cancer Drug Introduction
  • 10.11.4 Roche Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 10.11.5 Roche Recent Development
• 11.12 Bettapharma
  • 10.12.1 Bettapharma Company Details
  • 10.12.2 Bettapharma Business Overview
  • 10.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Introduction
  • 10.12.4 Bettapharma Revenue in Small Molecule Targeted Anti-cancer Drug Business (2015-2020)
  • 10.12.5 Bettapharma Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer